天眼查商业履历信息显示，浙江鼎力机械股份有限公司，成立于2005年，位于湖州市，是一家以从事通 用设备制造业为主的企业。企业注册资本50634.7879万人民币，实缴资本50634.7879万人民币。公司法 定代表人为许树根。 通过天眼查大数据分析，浙江鼎力机械股份有限公司共对外投资了9家企业，参与招投标项目66次，知 识产权方面有商标信息76条，专利信息468条，此外企业还拥有行政许可36个。 来源：金融界 金融界消息 截至2025年7月30日收盘，浙江鼎力（603338）报收于50.4元，下跌2.59%，换手率1.85%， 成交量9.35万手，成交金额4.74亿元。 资金流向方面，今日主力资金净流出4644.97万元，占比成交额9.79%。其中，超大单净流出692.68万 元、占成交额1.46%，大单净流出3952.29万元、占成交额8.33%，中单净流出流入1952.62万元、占成交 额4.12%，小单净流入2692.35万元、占成交额5.67%。 浙江鼎力最新一期业绩显示，截至2025一季报，公司营业总收入18.98亿元、同比增长30.72%，归属净 利润4.29亿元，同比增长41.83%，扣非净利润 ...

7月28日，浙江鼎力机械股份有限公司（以下简称"浙江鼎力"）发布2025年半年度业绩快报。2025年上 半年，浙江鼎力实现营业总收入43.36亿元，同比增长12.35%；实现营业利润12.61亿元，同比增长 29.39%；实现归属于上市公司股东的净利润10.51亿元，同比增长27.49%。 公告显示，面对海外市场的波动，浙江鼎力及时调整产线，调配市场，稳定生产，实现经营业绩稳步增 长。此外，欧元、英镑等外币汇率的波动也对公司的利润增长带来了积极影响。 盘古智库（北京）信息咨询有限公司高级研究员江瀚对《证券日报》记者表示："在同行企业中，浙江 鼎力的业绩增速处于领先水平。尤其在当前全球经济不确定性的背景下，公司通过优化内部管理、积极 应对外部挑战，不仅实现了业务的持续增长，还提升了盈利能力，为股东创造了可观价值。" 据悉，浙江鼎力从事各类智能高空作业平台的研发、制造、销售和服务，主要产品涵盖臂式、剪叉式和 桅柱式三大系列共200多款规格。其中海外地区是公司的主要销售市场，公司产品已远销全球100多个国 家和地区。财报显示，2022年至2024年，浙江鼎力的境外营业收入分别为33.88亿元、38.40亿元和55. ...

Core Viewpoint - Zhejiang Dingli, a leader in the aerial work platform sector, continues to show strong performance with significant revenue and profit growth in the first half of 2025 [1][2]. Financial Performance - In the first half of 2025, the company achieved total revenue of 4.336 billion yuan, a year-on-year increase of 12.35%, and a net profit of 1.051 billion yuan, up 27.49% [1]. - For the first quarter of 2025, revenue was 1.898 billion yuan, reflecting a 30.72% year-on-year growth, while net profit reached 429 million yuan, a 41.83% increase [2]. - Historical revenue figures show growth from 5.445 billion yuan in 2022 to 6.312 billion yuan in 2023, and projected 7.799 billion yuan in 2024, with respective year-on-year growth rates of 10.24%, 15.95%, and 23.56% [1]. Product Development - The company focuses on the research, manufacturing, sales, and service of intelligent aerial work platforms, with over 200 specifications across three main product series: boom, scissor, and mast [2]. - The boom series has been a key development area, generating 2.956 billion yuan in revenue in 2024, a 20.84% increase, accounting for 37.9% of total revenue [2]. - The scissor lift segment also saw growth, with revenue of 3.444 billion yuan in 2024, up 14.41% due to increased sales of large scissor products [2]. International Expansion - Zhejiang Dingli has made significant strides in international markets, with overseas revenue reaching 5.523 billion yuan in 2024, a 43.83% increase, and overseas revenue accounting for 70.9% of total revenue, up 10 percentage points from 2023 [2]. Research and Innovation - The company prioritizes innovation as a core competitive advantage, with R&D investments increasing from 105 million yuan in 2020 to 256 million yuan in 2024, totaling 938 million yuan over five years [3]. - Zhejiang Dingli has established overseas R&D centers and holds 280 patents, including 142 invention patents and 101 overseas patents, contributing to industry standards and technological advancements [3].

Group 1 - Zhejiang Dingli achieved a net profit of 1.051 billion yuan in the first half of 2025, a year-on-year increase of 27.49% [1] - The company reported an operating income of 4.336 billion yuan, representing a year-on-year growth of 12.35% [1] - Basic earnings per share were 2.08 yuan [1] Group 2 - Dexin Technology announced that its shareholder plans to reduce its stake by no more than 1%, equating to 2.3351 million shares [1] - The company specializes in the research, design, manufacturing, and sales of lithium battery cutting molds and precision components [1] Group 3 - Fangda Group signed new orders worth 970 million yuan in the second quarter of 2025 [1] - The total amount of signed but uncompleted contracts reached 4.916 billion yuan by the end of the second quarter [1] Group 4 - Warner Pharmaceutical's shareholder plans to reduce its stake by no more than 1.3 million shares, which is approximately 0.9899% of the total share capital [3] - The company focuses on the research, production, and sales of chemical raw materials and traditional Chinese medicine [3] Group 5 - Zijin Mining's vice president plans to reduce his holdings by no more than 250,300 shares [4] - The company is engaged in the exploration and development of mineral resources, including gold, copper, and lithium [4] Group 6 - Shenkong Co. received government subsidies totaling 14.9 million yuan [6] - The company specializes in the research, production, and sales of large-diameter silicon materials and semiconductor products [6] Group 7 - Jincai Hulin's shareholder plans to reduce its stake by no more than 2.5%, which amounts to 19.4798 million shares [1] - The company is involved in heat treatment equipment manufacturing and related services [1] Group 8 - New Media Co. plans to reduce its stake by no more than 6.8434 million shares, approximately 2.99% of the total share capital [1] - The company focuses on IPTV, internet audio-visual services, and content copyright [1] Group 9 - Aidi Pharmaceutical received a drug registration certificate for its product in Zanzibar, allowing for commercial sales [8] - The product is a new drug developed for the treatment of HIV-1 infection [8] Group 10 - Changlan Technology plans to reduce its stake by no more than 1%, equating to 1.9311 million shares [10] - The company specializes in the research, production, and sales of power cable accessories [10] Group 11 - Qiaofeng Intelligent announced that two shareholders plan to reduce their holdings by no more than 2.14% of the total share capital [12] - The company focuses on the research, production, and sales of CNC machine tools [12] Group 12 - Junxin Co. signed a tripartite preliminary agreement to build a solid waste disposal power facility valued at approximately 280 million USD in Almaty [13] - The company specializes in waste incineration power generation and related environmental services [13] Group 13 - Qinglong Pipe Industry signed a strategic cooperation framework agreement with Tian Shan High-tech [14] - The company is involved in the research, production, and sales of high-quality water supply pipes [14] Group 14 - Defang Nano's shareholder plans to reduce its stake by no more than 1%, equating to 2.7954 million shares [1] - The company specializes in the research, production, and sales of lithium-ion battery materials [1] Group 15 - ST Lutong's specific shareholder plans to reduce its stake by up to 3%, including 2 million shares through centralized bidding and 4 million shares through block trading [1] - The company focuses on cable television network equipment and smart control systems [1] Group 16 - Tongzhou Electronics reported a net profit of 203 million yuan in the first half of 2025, a significant turnaround from a loss of 36.08 million yuan in the previous year [17] - The company achieved an operating income of approximately 540 million yuan, representing a year-on-year growth of 606.52% [17] Group 17 - Rebecca reported a net profit of 9.3759 million yuan in the first half of 2025, a year-on-year increase of 15.31% [18] - The company achieved total operating revenue of approximately 598 million yuan, reflecting a year-on-year growth of 4.20% [18] Group 18 - Ruixin Technology's shareholders plan to reduce their holdings by no more than 4.9493 million shares, which is up to 3% of the total share capital [20] - The company specializes in the research, production, and sales of precision aluminum alloy components [20]

Company Analysis - Sanofi has entered a global licensing agreement with Pfizer for the PD-1/VEGF dual antibody 707, which includes an upfront payment of $1.25 billion, potential milestone payments of up to $4.8 billion, and a double-digit sales revenue share [2] - Pfizer will subscribe to 31,142,500 shares of Sanofi at HKD 25.2 per share, totaling approximately HKD 785 million (around $100 million) [2] - The agreement grants Pfizer an option for rights in China, which could yield an additional $150 million if exercised [2] Clinical Development Insights - The 707 antibody is noted for its differentiated structure, which may provide advantages in efficacy and safety compared to similar PD-1/VEGF dual antibodies [5] - Pfizer's management expressed confidence in the clinical data for 707, indicating its potential as a foundational treatment option for multiple indications [5][6] - The Phase II clinical data presented at ASCO showed a 64.7% confirmed overall response rate (cORR) in patients with PD-L1+ NSCLC [5] Market Outlook - Pfizer plans to accelerate the global Phase III clinical development of 707, exploring its use as a monotherapy and in combination with chemotherapy and ADCs [6] - The report maintains a "Buy" rating for Sanofi with a target price of HKD 37.67, reflecting an upward adjustment in sales expectations due to Pfizer's rapid development plans [6] Other Company Insights - Thermo Fisher Scientific reported a 3.0% year-over-year revenue growth in Q2 2025, with adjusted EPS declining by 0.2% [7] - The company has raised its full-year guidance, expecting revenue growth between 1.7% and 3.1% [7][8] - Zhejiang Dingli's Q2 2025 net profit increased by 19% year-over-year, primarily driven by foreign exchange gains [8]

证券代码：603338 证券简称：浙江鼎力 公告编号：2025-026 浙江鼎力机械股份有限公司董事会 | 单位：万元 | | | | | --- | --- | --- | --- | | 增减变动幅度 | | | | | 项目 本报告期 上年同期 | | | | | （％） | | | | | 营业总收入 433,611.83 385,945.51 12.35 | | | | | 营业利润 126,113.56 97,467.68 29.39 | | | | | 利润总额 126,147.64 97,498.66 29.38 | | | | | 归属于上市公司股东的净 | | | | | 利润 | | | | | 归属于上市公司股东的扣 | | | | | 除非经常性损益的净利润 | | | | | 基本每股收益（元） 1.63 | 27.61 | | 2.08 | | 增加 1 个百分 | | | | | 10.03 9.03 加权平均净资产收益率 | | | | | 点 | | | | | 增减变动幅度 | | | | | 本报告期末 本报告期初 | | | | | （％） | | | | | 1,6 ...

[Announcement Overview](index=1&type=section&id=%E5%85%AC%E5%91%8A%E6%A6%82%E8%A7%88) This section provides an overview of the preliminary earnings report, highlighting its unaudited nature and investment risk warnings [Announcement Statement](index=1&type=section&id=%E5%85%AC%E5%91%8A%E5%A3%B0%E6%98%8E) This section presents Zhejiang Dingli Machinery Co., Ltd.'s H1 2025 preliminary earnings report, emphasizing unaudited data and investment risk warnings - Zhejiang Dingli Machinery Co., Ltd. released its H1 2025 preliminary earnings report[1](index=1&type=chunk) - The announcement emphasizes that the financial data is preliminary, unaudited, and subject to the final regular report, with an investment risk warning[2](index=2&type=chunk) [Key Financial Data and Indicators](index=1&type=section&id=%E4%B8%80%E3%80%812025%E5%B9%B4%E5%8D%8A%E5%B9%B4%E5%BA%A6%E4%B8%BB%E8%A6%81%E8%B4%A2%E5%8A%A1%E6%95%B0%E6%8D%AE%E5%92%8C%E6%8C%87%E6%A0%87) This section presents the company's H1 2025 key financial data and indicators, showing significant growth compared to prior periods [Financial Data Overview](index=1&type=section&id=1.1%20%E8%B4%A2%E5%8A%A1%E6%95%B0%E6%8D%AE%E6%A6%82%E8%A7%88) This section outlines Zhejiang Dingli Machinery Co., Ltd.'s H1 2025 key financial data, comparing it to prior periods and highlighting significant growth across major indicators H1 2025 Key Financial Data and Indicators (Unit: RMB 10,000) | Item | Current Period | Prior Year Same Period | Change (%) | | :--- | :--- | :--- | :--- | | Total Operating Revenue | 433,611.83 | 385,945.51 | 12.35 | | Operating Profit | 126,113.56 | 97,467.68 | 29.39 | | Total Profit | 126,147.64 | 97,498.66 | 29.38 | | Net Profit Attributable to Shareholders of Listed Company | 105,099.00 | 82,437.70 | 27.49 | | Net Profit Attributable to Shareholders of Listed Company (Excluding Non-Recurring Gains/Losses) | 105,003.17 | 86,262.97 | 21.72 | | Basic Earnings Per Share (RMB) | 2.08 | 1.63 | 27.61 | | Weighted Average Return on Net Assets | 10.03 | 9.03 | increased by 1 percentage point | | Item | End of Current Period | Beginning of Current Period | Change (%) | | :--- | :--- | :--- | :--- | | Total Assets | 1,659,536.76 | 1,535,384.68 | 8.09 | | Owner's Equity Attributable to Shareholders of Listed Company | 1,057,600.59 | 1,003,529.58 | 5.39 | | Share Capital | 50,634.79 | 50,634.79 | - | | Net Assets Per Share Attributable to Shareholders of Listed Company (RMB) | 20.89 | 19.82 | 5.40 | *Note: 1. The figures at the beginning of the current period are the same as the legally disclosed figures at the end of the previous year. 2. The above data is prepared based on consolidated financial statements; the final results are subject to the company's H1 2025 semi-annual report. [Explanation of Operating Performance and Financial Position](index=2&type=section&id=%E4%BA%8C%E3%80%81%E7%BB%8F%E8%90%A5%E4%B8%9A%E7%BB%A9%E5%92%8C%E8%B4%A2%E5%8A%A1%E7%8A%B6%E5%86%B5%E6%83%85%E5%86%B5%E8%AF%B4%E6%98%8E) This section details the company's H1 2025 operating performance and financial position, including challenges and growth drivers [Operating Performance Analysis](index=2&type=section&id=2.1%20%E7%BB%8F%E8%90%A5%E4%B8%9A%E7%BB%A9%E5%88%86%E6%9E%90) The company achieved stable performance growth in H1 2025 despite US tariff challenges, driven by strategic adjustments and positive foreign exchange rate impacts - During the reporting period, the US imposed tariffs on over 180 countries and regions globally, with a **104% tariff on China in April-May** significantly impacting the company's exports to the US[6](index=6&type=chunk) - The company promptly adjusted production lines and markets to stabilize output; following the May 12 US-China joint statement, tariffs decreased to **34%**, allowing the company to resume production and shipments to the US[6](index=6&type=chunk) - Fluctuations in foreign currency exchange rates, such as the Euro and Pound Sterling, positively impacted profit growth[6](index=6&type=chunk) H1 2025 Key Financial Indicators and Year-on-Year Growth | Indicator | Amount (RMB 10,000) | Year-on-year Growth (%) | | :--- | :--- | :--- | | Total Operating Revenue | 433,611.83 | 12.35 | | Operating Profit | 126,113.56 | 29.39 | | Net Profit Attributable to Shareholders of Listed Company | 105,099.00 | 27.49 | June 30, 2025, Asset and Liability Indicators and Year-on-Year Growth | Indicator | Amount (RMB 10,000) | Year-on-year Growth (%) | | :--- | :--- | :--- | | Total Assets | 1,659,536.76 | 8.09 | | Owner's Equity Attributable to Shareholders of Listed Company | 1,057,600.59 | 5.39 | [Risk Warning](index=2&type=section&id=%E4%B8%89%E3%80%81%E9%A3%8E%E9%99%A9%E6%8F%90%E7%A4%BA) This section provides a risk warning regarding the preliminary nature of the financial data and advises investors on potential investment risks [Preliminary Earnings Report Risk Statement](index=2&type=section&id=3.1%20%E4%B8%9A%E7%BB%A9%E5%BF%AB%E6%8A%A5%E9%A3%8E%E9%99%A9%E5%A3%B0%E6%98%8E) The company advises investors that the preliminary earnings data is unaudited and subject to the final semi-annual report, emphasizing investment risks - The company confirms no significant uncertainties exist that would affect the accuracy of this preliminary earnings report[7](index=7&type=chunk) - The H1 2025 key financial data presented in this announcement is preliminary and has not been audited by an accounting firm[7](index=7&type=chunk) - Final specific data will be based on the company's H1 2025 semi-annual report, and investors are advised to be aware of investment risks[7](index=7&type=chunk)

Core Points - Zhejiang Dingli Machinery Co., Ltd. is holding its first extraordinary general meeting of shareholders in 2025 on August 8, 2025, at 14:30 [1] - The meeting will include both on-site and online voting, with specific time slots for participation [1][4] - The agenda includes the election of a new non-independent director and the proposal to cancel the supervisory board [4][6] Meeting Procedures - The meeting will start with a registration period from 14:00 to 14:30, followed by the introduction of attendees and reading of the meeting guidelines [1][2] - A secretariat will be established to manage the organization of the meeting and related matters [2] - Attendees must present identification and relevant documents to gain entry, and only authorized personnel will be allowed in the meeting [2][3] Voting Process - Voting will be conducted through a combination of on-site and online methods, with each shareholder having one vote per share [4] - The voting process will require shareholders to select "agree," "disagree," or "abstain" for each proposal, and any invalid votes will be counted as abstentions [4] Proposals - Proposal One: Cancellation of the supervisory board and amendment of the company’s articles of association, transferring supervisory powers to the audit committee of the board [4][5] - Proposal Two: Revision and establishment of certain management systems in accordance with updated laws and regulations [5][6] - Proposal Three: Election of a new non-independent director due to the resignation of a current board member [6][9] - Proposal Four: Renewal of the auditing firm, Li Xin Certified Public Accountants, for the fiscal year 2025 [8][10]

Investment Rating - The industry investment rating is "Overweight" [12] Core Viewpoints - The commencement of the Yarlung Zangbo River downstream hydropower project is expected to significantly benefit the engineering machinery sector, with a total investment of approximately 1.2 trillion yuan, making it the highest investment project in a single country [5][6] - The project will require a high degree of mechanization, with a projected demand for engineering machinery equipment amounting to about 120 billion yuan, which is estimated to be 10% of the total investment [5][6] - The geological conditions favor the use of tunnel boring machines (TBM), leading to an expected increase in the proportion of TBM construction methods [4][5] Summary by Sections General Engineering Machinery - General engineering machinery such as excavators, cranes, concrete machinery, and aerial work platforms will see increased demand due to the project's construction cycle and local conditions [4] - The demand for larger and electric equipment is anticipated to be higher, reflecting greater profitability for companies [4] Tunnel Boring Machinery - The project will utilize TBM and other drilling equipment, with expectations of more extensive tunnel construction compared to previous projects [4][5] - The average length of tunnels in similar projects has been noted to be around 16.7 kilometers, with the Yarlung Zangbo project expected to have even longer tunnels [4][5] Large Cable Cranes - Large cable cranes will be essential for transporting concrete and installing metal structures in the challenging mountainous terrain [4] Key Beneficiaries - Core companies to focus on include Sany Heavy Industry, XCMG, Zoomlion, LiuGong, and others for general engineering machinery; China Railway Engineering Corporation and others for tunnel boring machinery; and Farlantech for cable cranes [6]

浙江鼎力机械股份有限公司 2025 年第一次临时股东大会会议资料 二〇二五年八月八日 浙江鼎力机械股份有限公司 2025 年第一次临时股东大会议程 现场会议时间：2025 年 8 月 8 日 (星期五) 14:30。 网络投票时间：采用上海证券交易所网络投票系统，通过交易系统投票平 台的投票时间为股东大会召开当日的交易时间段，即 9:15-9:25，9:30-11:30， 13:00-15:00；通过互联网投票平台的投票时间为股东大会召开当日的 9:15- 15:00。 现场会议地点：浙江省湖州市德清县启航路188号。 会议主持人：董事长许树根先生。 会议议程: 一、与会人员签到（14:00—14:30）； 1.《关于取消监事会并修订<公司章程>的议案》 2.00.《关于修订、制定公司部分管理制度的议案》 2.01.《关于修订<股东会议事规则>的议案》 2.02.《关于修订<董事会议事规则>的议案》 2.03.《关于修订<独立董事工作制度>的议案》 2.04.《关于修订<授权管理制度>的议案》 2.05.《关于修订<对外担保管理制度>的议案》 二、大会开始，主持人介绍本次股东大会现场会议的出席情况； 三、宣读 ...